Literature DB >> 19296969

Complications in women undergoing Burch colposuspension versus autologous rectus fascial sling for stress urinary incontinence.

Toby C Chai1, Michael E Albo, Holly E Richter, Peggy A Norton, Kimberly J Dandreo, Kimberly Kenton, Jerry L Lowder, Anne M Stoddard.   

Abstract

PURPOSE: We determined the clinicodemographic factors associated with complications of continence procedures, the impact of concomitant surgery on the complication rate and the relationship between the incidence of cystitis and the method of postoperative bladder drainage.
MATERIALS AND METHODS: We reviewed serious adverse events and adverse events in the Stress Incontinence Surgical Efficacy Trial, a randomized trial comparing Burch colposuspension to the autologous rectus fascial sling. Clinicodemographic variables were analyzed to determine those associated with adverse events using logistic regression analysis. Complications were stratified based on the presence or absence of concomitant surgery. Differences in complication rates (controlling for concomitant surgery) and cystitis rates (controlling for the bladder emptying method) were compared using Fisher's exact test.
RESULTS: Blood loss (p = 0.0002) and operative time (p <0.0001) were significantly associated with an adverse event. Patients who underwent concomitant surgery had a significantly higher serious adverse event rate (14.2% vs 7.3%, p = 0.01) and adverse event rate (60.5% vs 48%, p <0.01) than patients who underwent continence surgery alone. Cystitis rates were higher in the sling vs the Burch group up to 6 weeks postoperatively regardless of concomitant surgery status (p <0.01). Intermittent self-catheterization increased the cystitis rate by 17% and 23% in the Burch and sling groups, respectively.
CONCLUSIONS: Concomitant surgery at continence surgery increased the risk of complications. Sling surgery was associated with a higher risk of cystitis within the first 6 weeks postoperatively. Intermittent self-catheterization increased the risk of cystitis in each group. Complications were associated with surgical factors and not with patient related factors.

Entities:  

Mesh:

Year:  2009        PMID: 19296969      PMCID: PMC2754071          DOI: 10.1016/j.juro.2009.01.019

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Design of the Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr).

Authors:  Sharon Tennstedt
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

2.  Obesity and retropubic surgery for stress incontinence: is there really an increased risk of intraoperative complications?

Authors:  R G Rogers; U Lebküchner; D N Kammerer-Doak; P K Thompson; M D Walters; I E Nygaard
Journal:  Am J Obstet Gynecol       Date:  2006-10-02       Impact factor: 8.661

3.  Incidence of concomitant surgery for pelvic organ prolapse in patients surgically treated for stress urinary incontinence.

Authors:  Stuart R Hart; Robert D Moore; John R Miklos; Thomas F Mattox; Neeraj Kohli
Journal:  J Reprod Med       Date:  2006-07       Impact factor: 0.142

4.  Perioperative complications of surgery for genital prolapse: does concomitant anti-incontinence surgery increase complications?

Authors:  Victoria L Handa; Lynn Harvey; Geoffrey W Cundiff; Kristen H Kjerulff
Journal:  Urology       Date:  2005-03       Impact factor: 2.649

5.  Incidence of concomitant procedures for pelvic organ prolapse and reconstruction in women who undergo surgery for stress urinary incontinence.

Authors:  C S Ng; R R Rackley; R A Appell
Journal:  Urology       Date:  2001-05       Impact factor: 2.649

6.  The effectiveness of surgery for stress incontinence in women: a systematic review.

Authors:  N A Black; S H Downs
Journal:  Br J Urol       Date:  1996-10

7.  Predictors of urinary tract infection after menopause: a prospective study.

Authors:  Sara L Jackson; Edward J Boyko; Delia Scholes; Linn Abraham; Kalpana Gupta; Stephan D Fihn
Journal:  Am J Med       Date:  2004-12-15       Impact factor: 4.965

8.  The effect of concomitant prolapse repair on sling outcomes.

Authors:  Jennifer T Anger; Mark S Litwin; Qin Wang; Chris L Pashos; Larissa V Rodríguez
Journal:  J Urol       Date:  2008-07-17       Impact factor: 7.450

9.  Burch colposuspension versus fascial sling to reduce urinary stress incontinence.

Authors:  Michael E Albo; Holly E Richter; Linda Brubaker; Peggy Norton; Stephen R Kraus; Philippe E Zimmern; Toby C Chai; Halina Zyczynski; Ananias C Diokno; Sharon Tennstedt; Charles Nager; L Keith Lloyd; MaryPat FitzGerald; Gary E Lemack; Harry W Johnson; Wendy Leng; Veronica Mallett; Anne M Stoddard; Shawn Menefee; R Edward Varner; Kimberly Kenton; Pam Moalli; Larry Sirls; Kimberly J Dandreo; John W Kusek; Leroy M Nyberg; William Steers
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

10.  The effect of age on outcomes of sling surgery for urinary incontinence.

Authors:  Jennifer T Anger; Mark S Litwin; Qin Wang; Chris L Pashos; Larissa V Rodríguez
Journal:  J Am Geriatr Soc       Date:  2007-12       Impact factor: 5.562

View more
  4 in total

Review 1.  Open retropubic colposuspension for urinary incontinence in women.

Authors:  Marie Carmela M Lapitan; June D Cody; Atefeh Mashayekhi
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25

Review 2.  Traditional suburethral sling operations for urinary incontinence in women.

Authors:  Haroon Rehman; Carlos A Bezerra; Homero Bruschini; June D Cody; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-26

Review 3.  Prophylactic antibiotics for preventing infection after continence surgery in women with stress urinary incontinence.

Authors:  Teerayut Temtanakitpaisan; Pranom Buppasiri; Pisake Lumbiganon; Malinee Laopaiboon; Siwanon Rattanakanokchai
Journal:  Cochrane Database Syst Rev       Date:  2022-03-29

4.  Traditional suburethral sling operations for urinary incontinence in women.

Authors:  Lucky Saraswat; Haroon Rehman; Muhammad Imran Omar; June D Cody; Patricia Aluko; Cathryn Ma Glazener
Journal:  Cochrane Database Syst Rev       Date:  2020-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.